About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDPhase 1NCT00300027

Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies

The purpose of this study is to define the recommended dose of BMS-582664 that could be safely combined with 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) or 5-fluorouracil, leucovorin, and oxa...

Lead sponsor: Bristol-Myers Squibb•6 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Bristol-Myers Squibb

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Good performance status
•Advanced colorectal, pancreatic, esophageal or gastric cancer
•Tissue for analyses
•Adequate bone marrow, hepatic, renal function
•4-6 weeks since prior therapy
•Adequate protection for women of child bearing potential (WOCBP)

Exclusion Criteria

•Brain metastasis
•Thromboembolic disease
•Cardiovascular disease

Related studies

RECRUITINGPhase 1

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms

RECRUITINGPhase 3

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

NCT07222800 · Intestinal Neoplasms, Gastrointestinal Neoplasms, and more

Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

NCT01750619 · Gastrointestinal Neoplasms, Benign Neoplasm of Intestinal Tract

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

NCT04907643 · Cancer Pain, Visceral Pain, and more

Enrolling By InvitationNA

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

NCT06048146 · Lymph Node Metastasis, Cancer of Rectum and Anus, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 2, 2010Terms

Trial snapshot

StatusTERMINATED

PhasePHASE1

Enrollment50

Start dateApr 2006

Last updatedMar 2, 2010

Condition

Gastrointestinal Neoplasms

Locations shown

Local Institution

Little Rock, Arkansas

Local Institution

Los Angeles, California

Local Institution

Washington D.C., District of Columbia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 2, 2010Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions